Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics

Tandem Diabetes Care, Inc. (TNDM): $42.75

0.13 (+0.31%)

POWR Rating

Component Grades














  • Value is the dimension where TNDM ranks best; there it ranks ahead of 77.24% of US stocks.
  • The strongest trend for TNDM is in Sentiment, which has been heading down over the past 179 days.
  • TNDM ranks lowest in Sentiment; there it ranks in the 1st percentile.

TNDM Stock Summary

  • Price to trailing twelve month operating cash flow for TNDM is currently 41.19, higher than 89.1% of US stocks with positive operating cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, TANDEM DIABETES CARE INC is reporting a growth rate of -291.19%; that's higher than only 5.49% of US stocks.
  • The volatility of TANDEM DIABETES CARE INC's share price is greater than that of 88.45% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to TANDEM DIABETES CARE INC are MKFG, MXCT, TBLA, RELY, and VRAY.
  • TNDM's SEC filings can be seen here. And to visit TANDEM DIABETES CARE INC's official web site, go to www.tandemdiabetes.com.

TNDM Valuation Summary

  • In comparison to the median Healthcare stock, TNDM's EV/EBIT ratio is 655.81% lower, now standing at -47.8.
  • Over the past 108 months, TNDM's price/sales ratio has gone down 17.2.

Below are key valuation metrics over time for TNDM.

Stock Date P/S P/B P/E EV/EBIT
TNDM 2022-11-25 3.2 6.0 -37.4 -47.8
TNDM 2022-11-23 3.2 6.0 -37.4 -47.8
TNDM 2022-11-22 3.0 5.7 -35.4 -45.5
TNDM 2022-11-21 3.1 5.9 -36.5 -46.8
TNDM 2022-11-18 3.1 5.9 -36.7 -46.9
TNDM 2022-11-17 3.2 6.0 -37.3 -47.6

TNDM Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 80.07%.
  • The 5 year cash and equivalents growth rate now stands at 59.57%.
  • Its 4 year revenue growth rate is now at 367.95%.
Over the past 18 months, TNDM's revenue has gone up $248,771,000.

The table below shows TNDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 790.712 64.279 -67.933
2022-06-30 765.792 74.48 -13.169
2022-03-31 737.669 96.474 5.895
2021-12-31 702.799 111.359 15.566
2021-09-30 660.868 106.961 21.758
2021-06-30 604.844 87.381 6.556

TNDM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TNDM has a Quality Grade of C, ranking ahead of 66.11% of graded US stocks.
  • TNDM's asset turnover comes in at 0.848 -- ranking 30th of 186 Medical Equipment stocks.
  • IVC, TCMD, and PSTV are the stocks whose asset turnover ratios are most correlated with TNDM.

The table below shows TNDM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.848 0.534 0.036
2021-06-30 0.823 0.532 0.024
2021-03-31 0.785 0.523 -0.018
2020-12-31 0.849 0.522 -0.045
2020-09-30 0.897 0.524 -0.109
2020-06-30 1.040 0.526 -0.154

TNDM Price Target

For more insight on analysts targets of TNDM, see our TNDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.75 Average Broker Recommendation 1.62 (Moderate Buy)

TNDM Stock Price Chart Interactive Chart >

Price chart for TNDM

TNDM Price/Volume Stats

Current price $42.75 52-week high $155.86
Prev. close $42.62 52-week low $33.51
Day low $42.04 Volume 588,200
Day high $43.53 Avg. volume 938,125
50-day MA $46.75 Dividend yield N/A
200-day MA $69.75 Market Cap 2.75B

Tandem Diabetes Care, Inc. (TNDM) Company Bio

Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.

TNDM Latest News Stream

Event/Time News Detail
Loading, please wait...

TNDM Latest Social Stream

Loading social stream, please wait...

View Full TNDM Social Stream

Latest TNDM News From Around the Web

Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

11 Best Diabetes Stocks To Buy Now

In this article, we discuss 11 best diabetes stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Diabetes Stocks To Buy Now. The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition. Based on the type, the […]

Yahoo | November 27, 2022

Is There An Opportunity With Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 49% Undervaluation?

In this article we are going to estimate the intrinsic value of Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ) by...

Yahoo | November 24, 2022

Tandem Diabetes Care Earns Great Place to Work Certification™

SAN DIEGO, November 16, 2022--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, is proud to announce its Great Place to Work Certification™, a prestigious award based entirely on results from in-depth employee surveys around their experience working at the company. This year, 84 percent of Tandem employees said it’s a great place to work – 27 points higher than the average participating company in the United States.

Yahoo | November 16, 2022

Buy These 2 Beaten-Growth Stocks Before They Soar

In the current market dip, growth stocks are leading the way, having lost the appeal they had during much of the 2010s. Let's look at two stocks that could soar once that happens: Tandem Diabetes Care (NASDAQ: TNDM) and Roku (NASDAQ: ROKU). Diabetes-focused medical device specialist Tandem Diabetes Care has had a terrible year, with shares plunging by 75%.

Yahoo | November 11, 2022

Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology

SAN DIEGO, November 10, 2022--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced results from a prospective, multicenter, single-arm study of adults living with type 2 diabetes who achieved improvement in all clinical endpoints with the use of the t:slim X2 insulin pump with Control-IQ technology.1

Yahoo | November 10, 2022

Read More 'TNDM' Stories Here

TNDM Price Returns

1-mo 19.68%
3-mo N/A
6-mo -33.99%
1-year -67.94%
3-year -30.91%
5-year 1,556.98%
YTD -71.60%
2021 57.32%
2020 60.51%
2019 56.99%
2018 1,508.90%
2017 -89.02%

Continue Researching TNDM

Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:

Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7752 seconds.